4//SEC Filing
CESCA THERAPEUTICS INC. 4
Accession 0001140361-17-020118
$THMOCIK 0000811212operating
Filed
May 11, 8:00 PM ET
Accepted
May 12, 4:33 PM ET
Size
6.8 KB
Accession
0001140361-17-020118
Insider Transaction Report
Form 4
JOSEPH THOMIS
Director
Transactions
- Award
Stock Options
2017-05-10$3.19/sh+12,250$39,078→ 12,250 totalExercise: $3.19Exp: 2027-05-10→ Common Stock (12,250 underlying)
Holdings
- 1,250
Stock Options
Exercise: $3.22Exp: 2024-01-10→ Common Stock (1,250 underlying)
Footnotes (2)
- [F1]The option vests as to 2,550 shares on the date of grant, 510 shares on the last day of each month thereafter for 18 months (beginning on June 30, 2017) and 520 shares on December 31, 2018, subject to the early termination provisions and other terms and conditions of the 2016 Equity Incentive Plan, as amended.
- [F2]Options vest monthly over a one year period.
Documents
Issuer
CESCA THERAPEUTICS INC.
CIK 0000811212
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000811212
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 4:33 PM ET
- Size
- 6.8 KB